1,25-ジヒドロキシコレカルシフェロールの小用量の長期効果は,腎臓の骨格不全に起因する
Lancet (London, England)
|March 25, 1978
まとめ
この研究は,1,25-dihydroxycholecalciferol (1,25-[OH]2D3) とカルシウム炭酸による治療が,腎臓骨縮症の慢性腎不全患者のカルシウム吸収と骨の健康を改善することを示しています.
科学分野:
- ネフロロジーはネフロロジーを用います.
- エンドクリノロジー エンドクリノロジー
- 骨代謝についてです.
背景:
- 慢性腎不全 (CRF) は,しばしば腎臓骨格不全につながる.
- 腎臓骨粗鬆症は,異常な骨代謝とミネラル不均衡によって特徴付けられます.
- ビタミンDの活性化障害とカルシウム・フォスファート不調は,CRFの合併症に寄与する.
研究 の 目的:
- 1,25-dihydroxycholecalciferol (1,25-[OH]2D3) の腎臓骨格不全の治療における有効性を評価する.
- 1,25-[OH]2D3がCRF患者におけるカルシウム吸収と骨転移マーカーに与える影響を評価する.
主な方法:
- 慢性腎不全および腎臓骨粗鬆症の患者5人は,1,25-[OH]2D3の0.5マイクログラムとカルシウム炭酸酸塩の4グラムの投与を毎日経口で受けていました.
- 治療期間は4ヶ月から16ヶ月でした.
- 評価されたパラメータには,腸内カルシウム吸収,血性アルカリリンフォスファターゼ,ヒドロキシプロリン,免疫反応性副甲状腺ホルモン,および骨組織学が含まれていました.
主要な成果:
- すべての患者は正常な腸内カルシウム吸収を達成しました.
- プラズマのアルカリリンフォスファタゼ,ヒドロキシプロリン,副甲状腺ホルモンの有意な減少が観察されました.
- 骨組織学では,鉱化が改善され,トラベキュラ構造が改造され,繊維症が減少し,特に副甲状腺機能障害の患者で改善された.
結論:
- 経口用1,25-[OH]2D3をカルシウム炭酸と併用すると,慢性腎不全における腎筋縮を効果的に治療します.
- この治療法は,カルシウム吸収を正常化し,骨疾患の生化学的および組織学的マーカーを改善します.
- この治療は,影響を受けた患者の骨鉱化と骨構造に有意な利点を示しています.
さらに関連する動画
04:24Proper Positioning and Restraint of a Rat Hind Limb for Focused High Resolution Imaging of Bone Micro-architecture Using In Vivo Micro-computed Tomography
Published on: November 22, 2017
06:47Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
関連する概念動画
Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
